Silencing of the ONECUT2 and VIM genes through promoter methylation has been observed in bladder tumors [303], while promoter hypermethylation of the CCNA1 and VIM genes is associated with esophageal cancer [304]. The gene discussed is VIM; the disease is urinary bladder neoplasm.